FILTER

FILTERED INTERVIEW RESULTS

Dr. Trevor P. Castor

PRESIDENT & CEO, APHIOS

United States Biopharmaceuticals 2020

Aphios’ vision is to develop biotechnology products for improving health and treating chronic diseases in an environmentally sustainable manner.

United States

Pharmaceuticals

Jay Shukla

PRESIDENT AND CEO, NIVAGEN PHARMACEUTICALS

United States Biopharmaceuticals 2020

Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and OTC products for the North American market.

United States

Pharmaceuticals

Doug Giordano

SENIOR VP OF BUSINESS DEVELOPMENT, PFIZER

United States Biopharmaceuticals 2019

Pfizer outlines its plans to build its pipeline through partnerships as the company increasingly focuses on new science.

United States

Pharmaceuticals

Michael Gladstone

PRINCIPAL, ATLAS VENTURE

United States Biopharmaceuticals 2019

Atlas Venture is an early-stage venture capital firm that invests in life sciences startup companies in the US.

United States

Pharmaceuticals

David DeJean

SENIOR VICE PRESIDENT, SYSTECH INTERNATIONAL

Systech International is a technology leader in supply chain safety and brand protection.

United States

Pharmaceuticals

Robert Foster

CEO, HEPION PHARMACEUTICALS

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease.

United States

Pharmaceuticals

Daniel J O’Connor

PRESIDENT & CEO, ONCOSEC MEDICAL INCORPORATED

OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using its plasmid DNA delivery platform.

United States

Pharmaceuticals

Peter Meath

MANAGING DIRECTOR & CO-HEAD OF HEALTHCARE AND LIFE SCIENCES, J.P. MORGAN COMMERCIAL BANKING

.P.Morgan explains the complete ecosystem that it has developed for life science companies, aiming to serve their needs throughout their entire life cycle, from opening a bank account on Day 1, to expanding internationally and through a potential IPO and beyond.

United States

Pharmaceuticals

John Patrick Oroho

EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER, PORZIO LIFE SCIENCES, LLC

Porzio Life Sciences, LLC (PorzioLS) is a provider of compliance operations products and services for the life sciences industry, and a wholly‐owned subsidiary of the Porzio, Bromberg & Newman, P.C. law firm.